Pancreas Ultrasound Imaging in type1 Diabetes
Sponsored by University of Colorado, Denver
About this trial
Last updated 3 years ago
Study ID
Status
Type
Placebo
Accepting
Trial Timing
Ended a year ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Male or non-pregnant female age 18-65
- Ability and willingness of patient to participate fully in all aspects of this clinical study
- Written informed consent obtained and documented
Exclusion Criteria
- BMI>30 (or excessive body size preventing effective scan of the pancreas)
- Evidence of exocrine pancreatic disease, including pancreatitis, cystic fibrosis, pancreatic adenocarcinoma, or neuroendocrine tumor.
- Subjects who are pregnant or breast-feeding
- Subjects incapable of giving assent/informed written consent
- Known or suspected hypersensitivity to perflutren
- Known history or suspected unstable cardiopulmonary conditions (acute myocardial infarction, acute coronary artery syndromes, worsening or unstable congestive heart failure, or serious ventricular arrhythmias)